TickerFacts.

A business in context

GRDN research notebook

Read the disclosures. Follow the relationships. Keep the dates in view.

Research JSON

Filing timeline

Download filings CSV

SEC submissions · retrieved 2026-10-22 · 8029 issuers; up to 32 recent company reports and 8 ownership-change filings per issuer

  1. 4 · Ownership change

    Report date 2026-09-27 · 0001193125-26-405595

  2. 4 · Ownership change

    Report date 2026-09-27 · 0001193125-26-405555

  3. 4 · Ownership change

    Report date 2026-09-27 · 0001193125-26-405544

  4. 4 · Ownership change

    Report date 2026-09-27 · 0001193125-26-405534

  5. 4 · Ownership change

    Report date 2026-09-27 · 0001193125-26-405524

  6. 4 · Ownership change

    Report date 2026-09-27 · 0001193125-26-405522

  7. 4 · Ownership change

    Report date 2026-09-27 · 0001193125-26-405521

  8. 4 · Ownership change

    Report date 2026-09-27 · 0001193125-26-405507

  9. 8-K · Current report

    Report date 2026-09-10 · 0001193125-26-387858 · Items 8.01

  10. 10-Q · Quarterly report

    Report date 2026-06-30 · 0001193125-26-338074

  11. 8-K · Current report

    Report date 2026-08-06 · 0001193125-26-338032 · Items 2.02,9.01

  12. 8-K · Current report

    Report date 2026-06-22 · 0001193125-26-277596 · Items 5.02,7.01,9.01

  13. 8-K · Current report

    Report date 2026-05-21 · 0001193125-26-245235 · Items 1.01,2.03,9.01

  14. 8-K · Current report

    Report date 2026-05-05 · 0001193125-26-211924 · Items 5.07

  15. 10-Q · Quarterly report

    Report date 2026-03-31 · 0001193125-26-209021

  16. 8-K · Current report

    Report date 2026-05-06 · 0001193125-26-208989 · Items 2.02,9.01

  17. DEF 14A · Proxy statement

    Report date 2026-05-05 · 0001193125-26-125070

  18. 8-K · Current report

    Report date 2026-03-18 · 0001193125-26-119772 · Items 1.01,8.01,9.01

  19. 10-K · Annual report

    Report date 2025-12-31 · 0001193125-26-102172

  20. 8-K · Current report

    Report date 2026-03-11 · 0001193125-26-102153 · Items 2.02,9.01

  21. 8-K · Current report

    Report date 2026-01-13 · 0001193125-26-011826 · Items 2.02,7.01,9.01

  22. 10-Q · Quarterly report

    Report date 2025-09-30 · 0001193125-25-274298

  23. 8-K · Current report

    Report date 2025-11-10 · 0001193125-25-274250 · Items 2.02,9.01

  24. 8-K · Current report

    Report date 2025-10-14 · 0001193125-25-239120 · Items 8.01

  25. 8-K · Current report

    Report date 2025-09-18 · 0001193125-25-206771 · Items 7.01,9.01

  26. 10-Q · Quarterly report

    Report date 2025-06-30 · 0001193125-25-177969

  27. 8-K · Current report

    Report date 2025-08-11 · 0001193125-25-177963 · Items 2.02,9.01

  28. 8-K · Current report

    Report date 2025-06-18 · 0001193125-25-142451 · Items 7.01,9.01

  29. 8-K · Current report

    Report date 2025-05-20 · 0001193125-25-123145 · Items 1.01,9.01

  30. 8-K · Current report

    Report date 2025-05-09 · 0001193125-25-117815 · Items 5.07

  31. 10-Q · Quarterly report

    Report date 2025-03-31 · 0001193125-25-117801

  32. 8-K · Current report

    Report date 2025-05-12 · 0001193125-25-117795 · Items 2.02,9.01

  33. 8-K · Current report

    Report date 2025-03-24 · 0001193125-25-067044 · Items 5.02

  34. DEF 14A · Proxy statement

    Report date 2025-05-09 · 0001193125-25-066235

  35. 10-K · Annual report

    Report date 2024-12-31 · 0001193125-25-064082

  36. 8-K · Current report

    Report date 2025-03-26 · 0001193125-25-064079 · Items 2.02,9.01

  37. 8-K · Current report

    Report date 2025-03-03 · 0001193125-25-043339 · Items 2.02,7.01,9.01

  38. 8-K · Current report

    Report date 2025-02-05 · 0001193125-25-024341 · Items 5.02

  39. 8-K · Current report

    Report date 2024-12-20 · 0001193125-24-283106 · Items 1.01,2.03,9.01

  40. SC 13G · Ownership disclosure

    0001085146-24-006029

Reported insider transactions

Download transactions CSV

SEC insider transactions · retrieved 2026-10-15 · 2026 Q3: filings in this completed quarter; not a live transaction feed

Purchases and sales include open-market or private transactions. Grants, exercises and tax withholding are shown separately. Amendments and joint reports can overlap; rows are not a net-buying score. Prices retain the filing's units; consult its footnotes.

Transaction rows by code · counts, not monetary totals
Purchase: 0 transaction rows0PSale: 0 transaction rows0SGrant / award: 0 transaction rows0AExercise / conversion: 34 transaction rows34MTax / exercise payment: 0 transaction rows0FGift: 0 transaction rows0G
P · PurchaseS · SaleA · Grant / awardM · Exercise / conversionF · Tax / exercise paymentG · Gift

34 matching transaction rows.

Transaction / filedReporting ownerTypeSecuritySharesReported price
2026-09-27
2026-09-28
Mudd William FranklinM · Exercise / conversion
Acquired
Class A Common Stock38282.0n/a
2026-09-27
2026-09-28
Mudd William FranklinM · Exercise / conversion
Disposed
Class B Common Stock
Derivative security
38282.0n/a
2026-09-27
2026-09-28
Weir RobertM · Exercise / conversion
Acquired
Class A Common Stock23450.0n/a
2026-09-27
2026-09-28
Weir RobertM · Exercise / conversion
Disposed
Class B Common Stock
Derivative security
23450.0n/a
2026-09-27
2026-09-28
Ackerman JohnM · Exercise / conversion
Acquired
Class A Common Stock471057.0n/a
2026-09-27
2026-09-28
Ackerman JohnM · Exercise / conversion
Acquired
Class A Common Stock1413939.0n/a
2026-09-27
2026-09-28
Ackerman JohnM · Exercise / conversion
Disposed
Class B Common Stock
Derivative security
471057.0n/a
2026-09-27
2026-09-28
Ackerman JohnM · Exercise / conversion
Disposed
Class B Common Stock
Derivative security
1413939.0n/a
2026-09-27
2026-09-28
Salentine Thomas J JrM · Exercise / conversion
Acquired
Class A Common Stock6100175.0n/a
2026-09-27
2026-09-28
Salentine Thomas J JrM · Exercise / conversion
Disposed
Class B Common Stock
Derivative security
6100175.0n/a
2026-09-27
2026-09-28
Martin David NormanM · Exercise / conversion
Acquired
Class A Common Stock39865.0n/a
2026-09-27
2026-09-28
Martin David NormanM · Exercise / conversion
Disposed
Class B Common Stock
Derivative security
39865.0n/a
2026-09-27
2026-09-28
Pharmacy Investors, LLCM · Exercise / conversion
Acquired
Class A Common Stock1413939.0n/a
2026-09-27
2026-09-28
Pharmacy Investors, LLCM · Exercise / conversion
Disposed
Class B Common Stock
Derivative security
1413939.0n/a
2026-09-27
2026-09-28
Burke FredM · Exercise / conversion
Acquired
Class A Common Stock1298825.0n/a
2026-09-27
2026-09-28
Burke FredM · Exercise / conversion
Disposed
Class B Common Stock
Derivative security
1298825.0n/a
2026-09-27
2026-09-28
Tuch JeffreyM · Exercise / conversion
Acquired
Class A Common Stock55578.0n/a
2026-09-27
2026-09-28
Tuch JeffreyM · Exercise / conversion
Disposed
Class B Common Stock
Derivative security
55578.0n/a
2026-09-27
2026-09-28
Forbes KendallM · Exercise / conversion
Acquired
Class A Common Stock608570.0n/a
2026-09-27
2026-09-28
Forbes KendallM · Exercise / conversion
Disposed
Class B Common Stock
Derivative security
608570.0n/a
2026-09-27
2026-09-28
BINDLEY WILLIAM EM · Exercise / conversion
Acquired
Class A Common Stock6100175.0n/a
2026-09-27
2026-09-28
BINDLEY WILLIAM EM · Exercise / conversion
Disposed
Class B Common Stock
Derivative security
6100175.0n/a
2026-09-27
2026-09-28
Morris David KM · Exercise / conversion
Acquired
Class A Common Stock641870.0n/a
2026-09-27
2026-09-28
Morris David KM · Exercise / conversion
Disposed
Class B Common Stock
Derivative security
641870.0n/a
2026-09-27
2026-09-28
Crisafulli ChrisM · Exercise / conversion
Acquired
Class A Common Stock18931.0n/a
2026-09-27
2026-09-28
Crisafulli ChrisM · Exercise / conversion
Disposed
Class B Common Stock
Derivative security
18931.0n/a
2026-09-27
2026-09-28
Eakins RichardM · Exercise / conversion
Acquired
Class A Common Stock36052.0n/a
2026-09-27
2026-09-28
Eakins RichardM · Exercise / conversion
Disposed
Class B Common Stock
Derivative security
36052.0n/a
2026-09-27
2026-09-28
Cardinal Equity Fund, L.P.M · Exercise / conversion
Acquired
Class A Common Stock471057.0n/a
2026-09-27
2026-09-28
Cardinal Equity Fund, L.P.M · Exercise / conversion
Disposed
Class B Common Stock
Derivative security
471057.0n/a
2026-09-27
2026-09-28
Bindley Capital Partners I, LLCM · Exercise / conversion
Acquired
Class A Common Stock6100175.0n/a
2026-09-27
2026-09-28
Bindley Capital Partners I, LLCM · Exercise / conversion
Disposed
Class B Common Stock
Derivative security
6100175.0n/a
2026-09-27
2026-09-28
Towns DouglasM · Exercise / conversion
Acquired
Class A Common Stock23450.0n/a
2026-09-27
2026-09-28
Towns DouglasM · Exercise / conversion
Disposed
Class B Common Stock
Derivative security
23450.0n/a

Identity & relationships

Wikidata structured data · retrieved 2026-10-15 · 1663 unambiguous CIK-linked entities; coverage is incomplete

These are sourced identity and relationship claims, with incomplete coverage. Headquarters locations do not describe sales, assets or operating exposure.

SEC issuer · 0001802255Guardian Pharmacy Services, Inc.

No parent relationship is available in this import; this is not proof of independence.

No verified LEI join available.

GLEIF legal entity reference data · retrieved 2026-10-15 · 1199 checked identities; 0 unavailable records

Search names and former names
  • Guardian Pharmacy Services, Inc. · former SEC name · 2020-03-11 to 2026-09-28
  • Guardian Pharmacy, LLC · former SEC name · 2020-02-13 to 2021-07-23

Revenue in constant purchasing power

USD revenue expressed in 2026-09 consumer-price dollars. Each annual period uses a CPI-U average weighted by the days in its actual reporting interval. This is a purchasing-power comparison, not a company-specific price or volume measure.

Year endedReported USD revenueCPI-adjusted USD revenue
2024-12-31$1.23B$1.32B

Bureau of Labor Statistics · retrieved 2026-10-22 · 9 selected series; gaps remain missing

Explore the CPI history ↗